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Abstract  
BACKGROUND: Chronic kidney disease (CKD) became a new epidemic of the twentieth and 
twenty-first centuries. Diabetic nephropathy is one of the leading causes of end-stage renal failure 
as a result of the diabetes epidemic worldwide.  
AIM: The aim of our study was to assess the prevalence of CKD in the Republic of Macedonia and 
its association with diabetes mellitus.  
MATERIALS AND METHODS: The study was a part of a study conducted in 2006 in terms of 
screening for early detection of kidney disease. It was a cross-sectional study based on a random 
sample of patients aged > 20, consecutively consulting their primary physician for any cause. Fifty 
physicians throughout the country were included in the study. A total of 2637 patients have been 
analyzed based on integrity data. GFR was estimated using corrected values of serum creatinine 
and calculating kidney function by the Cockroft & Gault formula, adjusted for body surface using the 
Gehan & George formula. Patients with estimated glomerular filtration rate (eGFR) less than 60 
ml/min were considered as having CKD. Blood pressure, body weight, height, serum creatinine, 
glucose, hemoglobin, hematocrit, urinalysis and medical history for presence of cardiovascular 
diseases or diabetes were also assessed. 
RESULTS: The mean age of the subjects was 45.97 ± 16.55 SD and 17.97% were older than 60. 
Regarding gender, 44.14% were males. The prevalence of diabetes mellitus was 13.9%. Subjects 
with CKD (eGFR less than 60 ml/min) were 7.53% of the total. Subjects aged 60 or above, had 20 
times higher risk of having CKD (eGFR less than 60 ml/min/1.73 m
2
). Out of the total group of 
subjects, 13.9% had diabetes mellitus and they had 3.13 times higher risk of having CKD stage 3-5 
(eGFR less than 60 ml/min/1.73 m
2
) when compared to non-diabetics. The results showed that 
diabetes was significantly more associated with lower eGFR (less than 60 ml/min/1.73 m
2
) in 
younger subjects (age less than 60) compared to older ones (odds ratio 3.29 versus 1.21). 
CONCLUSION: Our study showed that chronic kidney disease is frequent in the Republic of 
Macedonia and is associated with older age and diabetes. Diabetes had a significantly stronger 
association with CKD at younger age.  
 
 
 
Introduction 
 
Chronic kidney disease (CKD) became a new 
epidemic of the twentieth and twenty-first centuries. At 
present, it is a global problem, mainly because a 
variety of risk factors are being involved in its etiology 
and pathophysiology. It is not surprising that diabetic 
nephropathy is one of the leading causes of end-stage 
renal failure having in mind the diabetes epidemic 
worldwide [1]. 
The prevalence of CKD differs among 
countries and ethnicities. It is of great importance for 
the policy makers to know the prevalence of CKD, as 
it is associated with high morbidity and mortality and 
high cost of renal replacement therapy. Guidelines 
from the National Kidney Foundation’s Kidney 
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Disease Outcomes Quality Initiative (KDOQI) 
recommend estimating glomerular filtration rate and 
screening for albuminuria in patients with risk factors 
for chronic kidney disease, including diabetes, 
hypertension, systemic illnesses, age greater than 60 
years, and family history of chronic kidney disease. 
The glomerular filtration rate (GFR), calculated by 
using a prediction equation, detects chronic kidney 
disease more accurately than does the serum 
creatinine level alone; the GFR also is used for 
disease staging. Current KDOQI guidelines 
recommend screening for kidney disease with a 
serum creatinine measurement for use in GFR 
estimation and analysis of a random urine sample for 
albuminuria [2]. 
The prevalence of CKD has increased 
dramatically in the period of 1999 to 2007 in different 
countries around the world, developed, as well as 
developing countries. It has reached epidemic 
proportions with 10–13% of the populations in Taiwan, 
Iran, Japan, China, Canada, India and the USA [3]. 
The aim of this paper was to estimate the 
prevalence of CKD in the Republic of Macedonia and 
the association of diabetes mellitus in patients with 
CKD not on renal replacement therapy.  
 
 
Materials and Methods 
 
This study is part of a study conducted in 
August/September 2006 in terms of screening for 
early detection of kidney disease (SKROBB). It was a 
cross-sectional study based on a random sample of 
patients aged > 20, consecutively consulting their 
primary physician for any cause. Fifty physicians 
throughout the country were included in the study. A 
total of 3019 patients were included, but 2637 have 
been analyzed based on integrity data. The 
physicians were asked to fill in a questionnaire for 
demographic and medical history data. They were 
also required to measure blood pressure, body 
weight, height, serum creatinine, glucose, 
hemoglobin, hematocrit and urinalysis. Proteinuria 
(qualitatively, 1+ or more), and/or hematuria, and 
estimated glomerular filtration rate (eGFR) < 60 
ml/min per 1.73 m
2
 have been considered as markers 
of renal damage or of chronic kidney disease. Serum 
creatinine has been measured by the use of Jaffe’s 
method, and in order to minimize the differences 
among alkaline picrate methods regarding influence of 
protein on creatinine results, at least in 10% of all the 
samples of each laboratory creatinine has been 
measured at the reference laboratory at the Medical 
Faculty in Skopje. A correction factor for creatinine 
has been estimated in each laboratory in the country. 
The body surface area has been measured using the 
Gehan & George formula [4]. The eGFR has been 
estimated using the Cockroft & Gault formula 
(Calculated creatinine clearance = [(140-age) x 1.23 x 
BW(kg)/Scr ] x 0.85 if female). Gender, age, presence 
of cardiovascular diseases, hypertension, diabetes, 
anemia, and obesity (BMI) has been considered as 
risk factors for CKD. Hypertension was defined as 
systolic blood pressure (SBP) >140 mmHg and 
diastolic blood pressure > 90 mmHg or having medical 
history or being treated for hypertension [5]. Persons 
were considered diabetic if fasting blood glucose was 
more than 7.1 mmol/l, or having medical history or 
being treated for diabetes [6]. 
The prevalence of CKD was calculated after 
adjustment for age and gender to the general 
population (the population census in 2002 was taken; 
the total population aged > 20 was 1,429,642). 
Stage 1 and 2 CKD was considered on the 
basis of proteins in the urine (1+ or more) without 
evidence of urinary infection.  
Statistical analysis has been conducted using 
the software program Statistica for Windows 10.0. 
Student-t test was used to compare the numerical 
data. Mantel-Haenszel Chi-square test was used to 
see the relationship between two dichotomous 
variables. A p-value < 0.05 has been taken as 
statistically significant. 
 
 
Results 
 
The study included 2,637 subjects based on 
integrity data. The mean age of the subjects was 
45.97 ± 16.55 SD and 17.97% were older than 60. 
Regarding gender, 44.14% were males. The relevant 
demographic and clinical data were the following: 
prevalence of diabetes mellitus was 13.9%, 
hypertension had 36.37% of subjects, actual smokers 
were 28.02%%, previous smokers and non-smokers 
were 12.49% and 59.08% respectively. According to 
ethnicity, Macedonians were 74.42%, Albanians 
17.23%, Roma 5.67% and others 2.68%. Anemia 
(hemoglobin less than 110 g/l) had 8.52% of subjects, 
history of cardiovascular diseases 37.46%, subjects 
living in urban area were 83.63%, and rural 14.42 %. 
Table 1: Prevalence of CKD stages estimated by Cockroft-Gault 
(adjusted by age/gender) 
CKD 
stage 
% male Per million 
males 
% females Per million 
females 
% total Per million 
total 
Stage 1 3.97 39.758.00 3.2 32.445.00 3.57 35.673.4 
Stage 2 2.11 21.132.2 3.51 35.129.8 2.89 30.103.0 
Stage 3 5.5 54.969.7 8.4 84.357.0 7.1 71.384.9 
Stage 4 0.24 2385.5 0.27 2677.6 0.25 2548.6 
Stage 5 0.07 717.4 0.26 2622.9 0.18 1781.8 
Total     13.99  
 
Table 1 shows the prevalence of CKD stages 
in the investigated population adjusted by age and 
gender to the general population. The population 
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census in 2002 has been used. Stages 1 and 2 were 
defined by presence of proteins in the urine (1+ or 
more).  
Table 2 shows that subjects older than 60 
years have a 20 times greater risk of having CKD 
(eGFR less than 60 ml/min/1.73 m
2
) compared to 
those being less than 60 years of age. 
Table 2: Association of age and low eGFR 
Age eGFR > 60 ml/min/1.73m
2 
eGFR < 60 ml/min/1.73m
2
 
> 60 years 395 175 
< 60 year 2008 43 
Total 2403 218 
Mantel-Haenszel = 478.43; (95% CI: 14.6-29.4); OR = 20.7; p < 0.001. 
 
Table 3 shows the presence of diabetes in 
different levels of eGFR. Those having established 
CKD, eGFR less than 60 ml/min/1.73 m
2
 have higher 
percentage of diabetics compared to those with eGFR 
above 60 ml/min/1.73 m
2
.  
Table 3: Presence of diabetes mellitus (DM) in subjects 
according to the level of eGFR 
Egfr 
Ml/Min/1.73m
2 
Presence 
of DM 
Absence 
of DM 
Total No 
Data 
Total % 
>90 126 1431 1557 30 1587 7.9% 
60-89 166 632 798 18 816 20.3% 
30-59 64 140 204 3 207 30.9% 
15-29 2 5 7 0 7 28.6% 
<15 0 4 4 0 4 0 
Total 358 
(13.9%) 
2212 2570 51 2621  
 
Table 4 shows that those having diabetes 
have 3 times higher risk of having CKD (eGFR less 
than ml/min/1.73 m
2
) compared to those who do not 
have diabetes.  
Table 4: Association of diabetes and lower eGFR (less than 60 
ml/min/1.73 m
2
) 
Presence of DM GFR >60 ml/min/1.73 m
2
 GFR <60 ml/min/1.73 m
2
 
Yes 292 (81.6%) 66 (18.4%) 
No  2063 (93.3%) 149 (6.7%) 
Mantel-Haenszel = 54.9 (95% CI 2.28-4.28), OR- 3.13 p < 0.001. 
 
After correction for age, it appeared that 
subjects aged less than 60 and having diabetes, have 
greater risk for having lower eGFR (less than 60 
ml/min/1.73 m
2
) compared to subjects with diabetes 
that are older than 60 (Table 5). It indicates that 
diabetes is significantly more associated with lower 
eGFR in younger subjects. Age is a confounding 
variable. In order to see whether age (below/above 
60) will have an impact upon a subject with diabetes 
to have lower eGFR (less than 60 ml/min/1.73 m
2
), a 
statistical analysis using 3 x 2 table (2 x 2 x 2) was 
performed, and it showed a Chi-square of 5.991, 
degrees of freedom 1, and p = 0.0144. This result 
confirms that the difference in odds ratios between 
3.29 and 1.1 is significant. Thus, we can conclude that 
age significantly predisposes the subject with diabetes 
towards having lower eGFR.  
Table 5: Association of diabetes with lower eGFR after 
correction by age 
DM Age < 60 Age > 60 
GFR > 60 GFR < 60 GFR > 60 GFR < 60 
Yes 172 (94.5%) 10 (5.5%) 120 (68.2%) 56 (31.8%) 
No 1757 (98.3%) 31 (1.73%) 306 (72.2%) 118 (27.8%) 
For age less than 60: For age above 60: Mantel-Haenszel – 11.458, p < 0,001 Mantel-
Haenszel 0.959; p = 0.3274; 95% CI 1.58-6.83; 95% CI 0.826-1.77; OR-3.29; OR-1.21. 
 
 
Discussion 
 
Data on the epidemiology of CKD in 
predialysis stages exists only in a small minority of 
countries in Europe. So, there is lack of information on 
prevalence of CKD in the different stages in different 
countries [7]. The available studies from the USA, 
Europe, Australia, and Asia showed that the 
prevalence of CKD is about 9–13% in the general 
population. The incidence and prevalence of patients 
with CKD including end-stage renal disease (ESRD) 
have doubled in the past 10 years in the USA and it is 
increasing not only among adults in the United States 
but also worldwide [8-10]. The incidence and 
prevalence of CKD increase markedly at older age [9, 
11]. For example, in the Framingham Heart Study, the 
risk of developing stage 3 CKD was 2.36 times higher 
for each 10 years older age [11]. Additionally, the 
prevalence of stage 1 or 2 and stage 3 or 4 CKD 
among US adults has been reported to be 3.3 and 54 
times higher, respectively, for adults ≥70 versus 20 to 
39 years of age [9]. Our study also showed a strong 
correlation of age and CKD (20 times greater risk of 
having CKD if a subject is 60 years of age or older).  
In the study of Islam T. et al, for adults 20 to 
49, 50 to 69 and ≥ 70 years of age, the prevalence 
ratios (95% confidence interval) of stage 3 or 4 CKD 
associated with diagnosed diabetes mellitus were 
3.01 (1.35 – 6.74), 1.61 (1.15 – 2.25), 1.40 (1.15 – 
1.69), respectively, p-trend = 0.067; and 2.67 (0.53 – 
13.4), 1.35 (0.69 – 2.63), 1.08 (0.78 – 1.51), 
respectively, for undiagnosed diabetes mellitus (p-
trend = 0.369) [10]. Our study also showed strong 
correlation of diabetes mellitus and CKD, Subjects 
had 3 times higher risk of having CKD stage 3-5 if 
being a diabetic. Age in diabetic subjects was a 
confounding variable for having CKD in our study. 
Subjects with DM and older than 60 had 1.2 higher 
risk of having CKD, compared to those with DM and 
younger than 60 (who had 3.3 times higher risk of 
having CKD). In the study of Islam [12], although not 
statistically significant, there was also a trend towards 
lower prevalence ratios of stage 3 or 4 CKD at older 
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age for diagnosed (p-trend = 0.067) and undiagnosed 
diabetes mellitus (p-trend = 0.369). 
This study has two limitations. The study 
population were patients consecutively consulting 
their general physician for any reason, and not 
subjects from the general population. Therefore, a 
possible selection bias must be considered. The high 
number of patients with diabetes mellitus in the study 
population points out to this notion. Secondly, stage 1 
and 2 CKD were defined by qualitative measurement 
of protein in the urine, and not by albuminuria or 
albumin/creatinine ratio. Therefore, the presence of 
CKD stage1 and 2 may not be completely accurate. 
Hence, to show the association of age and diabetes 
with CKD, we take into consideration only CKD stage 
3-5 (eGFR less than 60 ml/min/1.73 m
2
). 
In conclusion, our study showed that chronic 
kidney disease is frequent in the Republic of 
Macedonia and is associated with risk factors as older 
age and diabetes. Diabetes mellitus is associated with 
stage 3 to 5 CKD across the full adult age range. But, 
this association was statistically significantly stronger 
at younger age. 
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